#PureHealth
The Abu Dhabi-listed healthcare platform said the acquisition is subject to regulatory approvals, without disclosing a timeline for its completion
PureHealth’s ongoing international expansion through Ardent Health reflects a broader ambition to reshape global healthcare landscapes
The sale will advance the healthcare firm’s focus on specialised services previously offered at Abu Dhabi Stem Cells Centre and Yas Clinic at Sheikh Shakbout Medical City
Valued at circa $1.2bn before debt, this acquisition firmly positions PureHealth in the global healthcare ecosystem.
The offering drew Dhs186bn in orders from professional investors within the UAE and the region
The healthcare firm is offering about 1.11 billion shares, equivalent to 10 per cent of the total issued share capital
Subject to obtaining regulatory approvals and other relevant considerations it is expected that trading on ADX will commence in December
The partnership with Dell further solidifies the healthcare’s position following the recent milestone acquisitions
The acquisition marks the healthcare group’s foray into the UK , as part of its global expansion programme
The healthcare firm’s climate pledge is a decade before the deadline by when the world must reach net zero if it is to achieve the Paris Agreement goal
The completion of the transaction is expected to further strengthen PureHealth’s vision towards becoming a leading global player in healthcare
The group chief operating officer of PureHealth shares her mission to transform the UAE into the land of longevity
The awards celebrated stalwarts and companies from across the region’s business landscape
The partnerships will play a significant role in boosting economic development through the National ICV Program
PureHealth aims to introduce technology-driven, personalised, preventive healthcare solutions that focus on increasing the average lifespan of individuals